Global Vaccine (Include COVID-19) Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Vaccine (Include COVID-19) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Vaccine (Include COVID-19) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Vaccine (Include COVID-19) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Vaccine (Include COVID-19) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Vaccine (Include COVID-19) players cover Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac and KM Biologics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and 'remember' it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
LPI (LP Information)' newest research report, the “Vaccine (Include COVID-19) Industry Forecast” looks at past sales and reviews total world Vaccine (Include COVID-19) sales in 2022, providing a comprehensive analysis by region and market sector of projected Vaccine (Include COVID-19) sales for 2023 through 2029. With Vaccine (Include COVID-19) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vaccine (Include COVID-19) industry.
This Insight Report provides a comprehensive analysis of the global Vaccine (Include COVID-19) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vaccine (Include COVID-19) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vaccine (Include COVID-19) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaccine (Include COVID-19) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaccine (Include COVID-19).
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine (Include COVID-19) market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
The global Vaccine (Include COVID-19) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Vaccine (Include COVID-19) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Vaccine (Include COVID-19) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Vaccine (Include COVID-19) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Vaccine (Include COVID-19) players cover Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac and KM Biologics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and 'remember' it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
LPI (LP Information)' newest research report, the “Vaccine (Include COVID-19) Industry Forecast” looks at past sales and reviews total world Vaccine (Include COVID-19) sales in 2022, providing a comprehensive analysis by region and market sector of projected Vaccine (Include COVID-19) sales for 2023 through 2029. With Vaccine (Include COVID-19) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vaccine (Include COVID-19) industry.
This Insight Report provides a comprehensive analysis of the global Vaccine (Include COVID-19) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vaccine (Include COVID-19) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vaccine (Include COVID-19) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaccine (Include COVID-19) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaccine (Include COVID-19).
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine (Include COVID-19) market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Inactivated Vaccine
- Attenuated Vaccine
- mRNA
- Other
- Public
- Private
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- CSL
- GSK
- Viatris
- AstraZeneca
- Hualan Bio
- Changchun Institute of Biological
- Sinovac
- KM Biologics
- Pfizer
- Merck
- Sinovac
- Zhejiang Pukang
- Walvax Biotechnology
- Bharat Biotech
- Serum Institute
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
- LG Life Sciences
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vaccine (Include COVID-19) Market Size 2018-2029
2.1.2 Vaccine (Include COVID-19) Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Vaccine (Include COVID-19) Segment by Type
2.2.1 Inactivated Vaccine
2.2.2 Attenuated Vaccine
2.2.3 mRNA
2.2.4 Other
2.3 Vaccine (Include COVID-19) Market Size by Type
2.3.1 Vaccine (Include COVID-19) Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Vaccine (Include COVID-19) Market Size Market Share by Type (2018-2023)
2.4 Vaccine (Include COVID-19) Segment by Application
2.4.1 Public
2.4.2 Private
2.5 Vaccine (Include COVID-19) Market Size by Application
2.5.1 Vaccine (Include COVID-19) Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Vaccine (Include COVID-19) Market Size Market Share by Application (2018-2023)
3 VACCINE (INCLUDE COVID-19) MARKET SIZE BY PLAYER
3.1 Vaccine (Include COVID-19) Market Size Market Share by Players
3.1.1 Global Vaccine (Include COVID-19) Revenue by Players (2018-2023)
3.1.2 Global Vaccine (Include COVID-19) Revenue Market Share by Players (2018-2023)
3.2 Global Vaccine (Include COVID-19) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 VACCINE (INCLUDE COVID-19) BY REGIONS
4.1 Vaccine (Include COVID-19) Market Size by Regions (2018-2023)
4.2 Americas Vaccine (Include COVID-19) Market Size Growth (2018-2023)
4.3 APAC Vaccine (Include COVID-19) Market Size Growth (2018-2023)
4.4 Europe Vaccine (Include COVID-19) Market Size Growth (2018-2023)
4.5 Middle East & Africa Vaccine (Include COVID-19) Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Vaccine (Include COVID-19) Market Size by Country (2018-2023)
5.2 Americas Vaccine (Include COVID-19) Market Size by Type (2018-2023)
5.3 Americas Vaccine (Include COVID-19) Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccine (Include COVID-19) Market Size by Region (2018-2023)
6.2 APAC Vaccine (Include COVID-19) Market Size by Type (2018-2023)
6.3 APAC Vaccine (Include COVID-19) Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Vaccine (Include COVID-19) by Country (2018-2023)
7.2 Europe Vaccine (Include COVID-19) Market Size by Type (2018-2023)
7.3 Europe Vaccine (Include COVID-19) Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vaccine (Include COVID-19) by Region (2018-2023)
8.2 Middle East & Africa Vaccine (Include COVID-19) Market Size by Type (2018-2023)
8.3 Middle East & Africa Vaccine (Include COVID-19) Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL VACCINE (INCLUDE COVID-19) MARKET FORECAST
10.1 Global Vaccine (Include COVID-19) Forecast by Regions (2024-2029)
10.1.1 Global Vaccine (Include COVID-19) Forecast by Regions (2024-2029)
10.1.2 Americas Vaccine (Include COVID-19) Forecast
10.1.3 APAC Vaccine (Include COVID-19) Forecast
10.1.4 Europe Vaccine (Include COVID-19) Forecast
10.1.5 Middle East & Africa Vaccine (Include COVID-19) Forecast
10.2 Americas Vaccine (Include COVID-19) Forecast by Country (2024-2029)
10.2.1 United States Vaccine (Include COVID-19) Market Forecast
10.2.2 Canada Vaccine (Include COVID-19) Market Forecast
10.2.3 Mexico Vaccine (Include COVID-19) Market Forecast
10.2.4 Brazil Vaccine (Include COVID-19) Market Forecast
10.3 APAC Vaccine (Include COVID-19) Forecast by Region (2024-2029)
10.3.1 China Vaccine (Include COVID-19) Market Forecast
10.3.2 Japan Vaccine (Include COVID-19) Market Forecast
10.3.3 Korea Vaccine (Include COVID-19) Market Forecast
10.3.4 Southeast Asia Vaccine (Include COVID-19) Market Forecast
10.3.5 India Vaccine (Include COVID-19) Market Forecast
10.3.6 Australia Vaccine (Include COVID-19) Market Forecast
10.4 Europe Vaccine (Include COVID-19) Forecast by Country (2024-2029)
10.4.1 Germany Vaccine (Include COVID-19) Market Forecast
10.4.2 France Vaccine (Include COVID-19) Market Forecast
10.4.3 UK Vaccine (Include COVID-19) Market Forecast
10.4.4 Italy Vaccine (Include COVID-19) Market Forecast
10.4.5 Russia Vaccine (Include COVID-19) Market Forecast
10.5 Middle East & Africa Vaccine (Include COVID-19) Forecast by Region (2024-2029)
10.5.1 Egypt Vaccine (Include COVID-19) Market Forecast
10.5.2 South Africa Vaccine (Include COVID-19) Market Forecast
10.5.3 Israel Vaccine (Include COVID-19) Market Forecast
10.5.4 Turkey Vaccine (Include COVID-19) Market Forecast
10.5.5 GCC Countries Vaccine (Include COVID-19) Market Forecast
10.6 Global Vaccine (Include COVID-19) Forecast by Type (2024-2029)
10.7 Global Vaccine (Include COVID-19) Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Vaccine (Include COVID-19) Product Offered
11.1.3 Sanofi Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 CSL
11.2.1 CSL Company Information
11.2.2 CSL Vaccine (Include COVID-19) Product Offered
11.2.3 CSL Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 CSL Main Business Overview
11.2.5 CSL Latest Developments
11.3 GSK
11.3.1 GSK Company Information
11.3.2 GSK Vaccine (Include COVID-19) Product Offered
11.3.3 GSK Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 GSK Main Business Overview
11.3.5 GSK Latest Developments
11.4 Viatris
11.4.1 Viatris Company Information
11.4.2 Viatris Vaccine (Include COVID-19) Product Offered
11.4.3 Viatris Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Viatris Main Business Overview
11.4.5 Viatris Latest Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Information
11.5.2 AstraZeneca Vaccine (Include COVID-19) Product Offered
11.5.3 AstraZeneca Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 AstraZeneca Main Business Overview
11.5.5 AstraZeneca Latest Developments
11.6 Hualan Bio
11.6.1 Hualan Bio Company Information
11.6.2 Hualan Bio Vaccine (Include COVID-19) Product Offered
11.6.3 Hualan Bio Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Hualan Bio Main Business Overview
11.6.5 Hualan Bio Latest Developments
11.7 Changchun Institute of Biological
11.7.1 Changchun Institute of Biological Company Information
11.7.2 Changchun Institute of Biological Vaccine (Include COVID-19) Product Offered
11.7.3 Changchun Institute of Biological Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Changchun Institute of Biological Main Business Overview
11.7.5 Changchun Institute of Biological Latest Developments
11.8 Sinovac
11.8.1 Sinovac Company Information
11.8.2 Sinovac Vaccine (Include COVID-19) Product Offered
11.8.3 Sinovac Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Sinovac Main Business Overview
11.8.5 Sinovac Latest Developments
11.9 KM Biologics
11.9.1 KM Biologics Company Information
11.9.2 KM Biologics Vaccine (Include COVID-19) Product Offered
11.9.3 KM Biologics Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 KM Biologics Main Business Overview
11.9.5 KM Biologics Latest Developments
11.10 Pfizer
11.10.1 Pfizer Company Information
11.10.2 Pfizer Vaccine (Include COVID-19) Product Offered
11.10.3 Pfizer Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Pfizer Main Business Overview
11.10.5 Pfizer Latest Developments
11.11 Merck
11.11.1 Merck Company Information
11.11.2 Merck Vaccine (Include COVID-19) Product Offered
11.11.3 Merck Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Merck Main Business Overview
11.11.5 Merck Latest Developments
11.12 Sinovac
11.12.1 Sinovac Company Information
11.12.2 Sinovac Vaccine (Include COVID-19) Product Offered
11.12.3 Sinovac Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Sinovac Main Business Overview
11.12.5 Sinovac Latest Developments
11.13 Zhejiang Pukang
11.13.1 Zhejiang Pukang Company Information
11.13.2 Zhejiang Pukang Vaccine (Include COVID-19) Product Offered
11.13.3 Zhejiang Pukang Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Zhejiang Pukang Main Business Overview
11.13.5 Zhejiang Pukang Latest Developments
11.14 Walvax Biotechnology
11.14.1 Walvax Biotechnology Company Information
11.14.2 Walvax Biotechnology Vaccine (Include COVID-19) Product Offered
11.14.3 Walvax Biotechnology Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Walvax Biotechnology Main Business Overview
11.14.5 Walvax Biotechnology Latest Developments
11.15 Bharat Biotech
11.15.1 Bharat Biotech Company Information
11.15.2 Bharat Biotech Vaccine (Include COVID-19) Product Offered
11.15.3 Bharat Biotech Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Bharat Biotech Main Business Overview
11.15.5 Bharat Biotech Latest Developments
11.16 Serum Institute
11.16.1 Serum Institute Company Information
11.16.2 Serum Institute Vaccine (Include COVID-19) Product Offered
11.16.3 Serum Institute Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Serum Institute Main Business Overview
11.16.5 Serum Institute Latest Developments
11.17 Panacea Biotec Ltd
11.17.1 Panacea Biotec Ltd Company Information
11.17.2 Panacea Biotec Ltd Vaccine (Include COVID-19) Product Offered
11.17.3 Panacea Biotec Ltd Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Panacea Biotec Ltd Main Business Overview
11.17.5 Panacea Biotec Ltd Latest Developments
11.18 Bio-Med
11.18.1 Bio-Med Company Information
11.18.2 Bio-Med Vaccine (Include COVID-19) Product Offered
11.18.3 Bio-Med Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Bio-Med Main Business Overview
11.18.5 Bio-Med Latest Developments
11.19 Halfkin Bio-Pharmaceuticals
11.19.1 Halfkin Bio-Pharmaceuticals Company Information
11.19.2 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Product Offered
11.19.3 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Halfkin Bio-Pharmaceuticals Main Business Overview
11.19.5 Halfkin Bio-Pharmaceuticals Latest Developments
11.20 LG Life Sciences
11.20.1 LG Life Sciences Company Information
11.20.2 LG Life Sciences Vaccine (Include COVID-19) Product Offered
11.20.3 LG Life Sciences Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 LG Life Sciences Main Business Overview
11.20.5 LG Life Sciences Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vaccine (Include COVID-19) Market Size 2018-2029
2.1.2 Vaccine (Include COVID-19) Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Vaccine (Include COVID-19) Segment by Type
2.2.1 Inactivated Vaccine
2.2.2 Attenuated Vaccine
2.2.3 mRNA
2.2.4 Other
2.3 Vaccine (Include COVID-19) Market Size by Type
2.3.1 Vaccine (Include COVID-19) Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Vaccine (Include COVID-19) Market Size Market Share by Type (2018-2023)
2.4 Vaccine (Include COVID-19) Segment by Application
2.4.1 Public
2.4.2 Private
2.5 Vaccine (Include COVID-19) Market Size by Application
2.5.1 Vaccine (Include COVID-19) Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Vaccine (Include COVID-19) Market Size Market Share by Application (2018-2023)
3 VACCINE (INCLUDE COVID-19) MARKET SIZE BY PLAYER
3.1 Vaccine (Include COVID-19) Market Size Market Share by Players
3.1.1 Global Vaccine (Include COVID-19) Revenue by Players (2018-2023)
3.1.2 Global Vaccine (Include COVID-19) Revenue Market Share by Players (2018-2023)
3.2 Global Vaccine (Include COVID-19) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 VACCINE (INCLUDE COVID-19) BY REGIONS
4.1 Vaccine (Include COVID-19) Market Size by Regions (2018-2023)
4.2 Americas Vaccine (Include COVID-19) Market Size Growth (2018-2023)
4.3 APAC Vaccine (Include COVID-19) Market Size Growth (2018-2023)
4.4 Europe Vaccine (Include COVID-19) Market Size Growth (2018-2023)
4.5 Middle East & Africa Vaccine (Include COVID-19) Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Vaccine (Include COVID-19) Market Size by Country (2018-2023)
5.2 Americas Vaccine (Include COVID-19) Market Size by Type (2018-2023)
5.3 Americas Vaccine (Include COVID-19) Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccine (Include COVID-19) Market Size by Region (2018-2023)
6.2 APAC Vaccine (Include COVID-19) Market Size by Type (2018-2023)
6.3 APAC Vaccine (Include COVID-19) Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Vaccine (Include COVID-19) by Country (2018-2023)
7.2 Europe Vaccine (Include COVID-19) Market Size by Type (2018-2023)
7.3 Europe Vaccine (Include COVID-19) Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vaccine (Include COVID-19) by Region (2018-2023)
8.2 Middle East & Africa Vaccine (Include COVID-19) Market Size by Type (2018-2023)
8.3 Middle East & Africa Vaccine (Include COVID-19) Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL VACCINE (INCLUDE COVID-19) MARKET FORECAST
10.1 Global Vaccine (Include COVID-19) Forecast by Regions (2024-2029)
10.1.1 Global Vaccine (Include COVID-19) Forecast by Regions (2024-2029)
10.1.2 Americas Vaccine (Include COVID-19) Forecast
10.1.3 APAC Vaccine (Include COVID-19) Forecast
10.1.4 Europe Vaccine (Include COVID-19) Forecast
10.1.5 Middle East & Africa Vaccine (Include COVID-19) Forecast
10.2 Americas Vaccine (Include COVID-19) Forecast by Country (2024-2029)
10.2.1 United States Vaccine (Include COVID-19) Market Forecast
10.2.2 Canada Vaccine (Include COVID-19) Market Forecast
10.2.3 Mexico Vaccine (Include COVID-19) Market Forecast
10.2.4 Brazil Vaccine (Include COVID-19) Market Forecast
10.3 APAC Vaccine (Include COVID-19) Forecast by Region (2024-2029)
10.3.1 China Vaccine (Include COVID-19) Market Forecast
10.3.2 Japan Vaccine (Include COVID-19) Market Forecast
10.3.3 Korea Vaccine (Include COVID-19) Market Forecast
10.3.4 Southeast Asia Vaccine (Include COVID-19) Market Forecast
10.3.5 India Vaccine (Include COVID-19) Market Forecast
10.3.6 Australia Vaccine (Include COVID-19) Market Forecast
10.4 Europe Vaccine (Include COVID-19) Forecast by Country (2024-2029)
10.4.1 Germany Vaccine (Include COVID-19) Market Forecast
10.4.2 France Vaccine (Include COVID-19) Market Forecast
10.4.3 UK Vaccine (Include COVID-19) Market Forecast
10.4.4 Italy Vaccine (Include COVID-19) Market Forecast
10.4.5 Russia Vaccine (Include COVID-19) Market Forecast
10.5 Middle East & Africa Vaccine (Include COVID-19) Forecast by Region (2024-2029)
10.5.1 Egypt Vaccine (Include COVID-19) Market Forecast
10.5.2 South Africa Vaccine (Include COVID-19) Market Forecast
10.5.3 Israel Vaccine (Include COVID-19) Market Forecast
10.5.4 Turkey Vaccine (Include COVID-19) Market Forecast
10.5.5 GCC Countries Vaccine (Include COVID-19) Market Forecast
10.6 Global Vaccine (Include COVID-19) Forecast by Type (2024-2029)
10.7 Global Vaccine (Include COVID-19) Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Vaccine (Include COVID-19) Product Offered
11.1.3 Sanofi Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 CSL
11.2.1 CSL Company Information
11.2.2 CSL Vaccine (Include COVID-19) Product Offered
11.2.3 CSL Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 CSL Main Business Overview
11.2.5 CSL Latest Developments
11.3 GSK
11.3.1 GSK Company Information
11.3.2 GSK Vaccine (Include COVID-19) Product Offered
11.3.3 GSK Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 GSK Main Business Overview
11.3.5 GSK Latest Developments
11.4 Viatris
11.4.1 Viatris Company Information
11.4.2 Viatris Vaccine (Include COVID-19) Product Offered
11.4.3 Viatris Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Viatris Main Business Overview
11.4.5 Viatris Latest Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Information
11.5.2 AstraZeneca Vaccine (Include COVID-19) Product Offered
11.5.3 AstraZeneca Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 AstraZeneca Main Business Overview
11.5.5 AstraZeneca Latest Developments
11.6 Hualan Bio
11.6.1 Hualan Bio Company Information
11.6.2 Hualan Bio Vaccine (Include COVID-19) Product Offered
11.6.3 Hualan Bio Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Hualan Bio Main Business Overview
11.6.5 Hualan Bio Latest Developments
11.7 Changchun Institute of Biological
11.7.1 Changchun Institute of Biological Company Information
11.7.2 Changchun Institute of Biological Vaccine (Include COVID-19) Product Offered
11.7.3 Changchun Institute of Biological Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Changchun Institute of Biological Main Business Overview
11.7.5 Changchun Institute of Biological Latest Developments
11.8 Sinovac
11.8.1 Sinovac Company Information
11.8.2 Sinovac Vaccine (Include COVID-19) Product Offered
11.8.3 Sinovac Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Sinovac Main Business Overview
11.8.5 Sinovac Latest Developments
11.9 KM Biologics
11.9.1 KM Biologics Company Information
11.9.2 KM Biologics Vaccine (Include COVID-19) Product Offered
11.9.3 KM Biologics Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 KM Biologics Main Business Overview
11.9.5 KM Biologics Latest Developments
11.10 Pfizer
11.10.1 Pfizer Company Information
11.10.2 Pfizer Vaccine (Include COVID-19) Product Offered
11.10.3 Pfizer Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Pfizer Main Business Overview
11.10.5 Pfizer Latest Developments
11.11 Merck
11.11.1 Merck Company Information
11.11.2 Merck Vaccine (Include COVID-19) Product Offered
11.11.3 Merck Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Merck Main Business Overview
11.11.5 Merck Latest Developments
11.12 Sinovac
11.12.1 Sinovac Company Information
11.12.2 Sinovac Vaccine (Include COVID-19) Product Offered
11.12.3 Sinovac Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Sinovac Main Business Overview
11.12.5 Sinovac Latest Developments
11.13 Zhejiang Pukang
11.13.1 Zhejiang Pukang Company Information
11.13.2 Zhejiang Pukang Vaccine (Include COVID-19) Product Offered
11.13.3 Zhejiang Pukang Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Zhejiang Pukang Main Business Overview
11.13.5 Zhejiang Pukang Latest Developments
11.14 Walvax Biotechnology
11.14.1 Walvax Biotechnology Company Information
11.14.2 Walvax Biotechnology Vaccine (Include COVID-19) Product Offered
11.14.3 Walvax Biotechnology Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Walvax Biotechnology Main Business Overview
11.14.5 Walvax Biotechnology Latest Developments
11.15 Bharat Biotech
11.15.1 Bharat Biotech Company Information
11.15.2 Bharat Biotech Vaccine (Include COVID-19) Product Offered
11.15.3 Bharat Biotech Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Bharat Biotech Main Business Overview
11.15.5 Bharat Biotech Latest Developments
11.16 Serum Institute
11.16.1 Serum Institute Company Information
11.16.2 Serum Institute Vaccine (Include COVID-19) Product Offered
11.16.3 Serum Institute Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Serum Institute Main Business Overview
11.16.5 Serum Institute Latest Developments
11.17 Panacea Biotec Ltd
11.17.1 Panacea Biotec Ltd Company Information
11.17.2 Panacea Biotec Ltd Vaccine (Include COVID-19) Product Offered
11.17.3 Panacea Biotec Ltd Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Panacea Biotec Ltd Main Business Overview
11.17.5 Panacea Biotec Ltd Latest Developments
11.18 Bio-Med
11.18.1 Bio-Med Company Information
11.18.2 Bio-Med Vaccine (Include COVID-19) Product Offered
11.18.3 Bio-Med Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Bio-Med Main Business Overview
11.18.5 Bio-Med Latest Developments
11.19 Halfkin Bio-Pharmaceuticals
11.19.1 Halfkin Bio-Pharmaceuticals Company Information
11.19.2 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Product Offered
11.19.3 Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Halfkin Bio-Pharmaceuticals Main Business Overview
11.19.5 Halfkin Bio-Pharmaceuticals Latest Developments
11.20 LG Life Sciences
11.20.1 LG Life Sciences Company Information
11.20.2 LG Life Sciences Vaccine (Include COVID-19) Product Offered
11.20.3 LG Life Sciences Vaccine (Include COVID-19) Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 LG Life Sciences Main Business Overview
11.20.5 LG Life Sciences Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Vaccine (Include COVID-19) Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Inactivated Vaccine
Table 3. Major Players of Attenuated Vaccine
Table 4. Major Players of mRNA
Table 5. Major Players of Other
Table 6. Vaccine (Include COVID-19) Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Vaccine (Include COVID-19) Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Vaccine (Include COVID-19) Market Size Market Share by Type (2018-2023)
Table 9. Vaccine (Include COVID-19) Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Vaccine (Include COVID-19) Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Vaccine (Include COVID-19) Market Size Market Share by Application (2018-2023)
Table 12. Global Vaccine (Include COVID-19) Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Vaccine (Include COVID-19) Revenue Market Share by Player (2018-2023)
Table 14. Vaccine (Include COVID-19) Key Players Head office and Products Offered
Table 15. Vaccine (Include COVID-19) Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Vaccine (Include COVID-19) Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Vaccine (Include COVID-19) Market Size Market Share by Regions (2018-2023)
Table 20. Global Vaccine (Include COVID-19) Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Vaccine (Include COVID-19) Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Vaccine (Include COVID-19) Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Vaccine (Include COVID-19) Market Size Market Share by Country (2018-2023)
Table 24. Americas Vaccine (Include COVID-19) Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Vaccine (Include COVID-19) Market Size Market Share by Type (2018-2023)
Table 26. Americas Vaccine (Include COVID-19) Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Vaccine (Include COVID-19) Market Size Market Share by Application (2018-2023)
Table 28. APAC Vaccine (Include COVID-19) Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Vaccine (Include COVID-19) Market Size Market Share by Region (2018-2023)
Table 30. APAC Vaccine (Include COVID-19) Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Vaccine (Include COVID-19) Market Size Market Share by Type (2018-2023)
Table 32. APAC Vaccine (Include COVID-19) Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Vaccine (Include COVID-19) Market Size Market Share by Application (2018-2023)
Table 34. Europe Vaccine (Include COVID-19) Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Vaccine (Include COVID-19) Market Size Market Share by Country (2018-2023)
Table 36. Europe Vaccine (Include COVID-19) Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Vaccine (Include COVID-19) Market Size Market Share by Type (2018-2023)
Table 38. Europe Vaccine (Include COVID-19) Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Vaccine (Include COVID-19) Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Vaccine (Include COVID-19) Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Vaccine (Include COVID-19) Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Vaccine (Include COVID-19) Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Vaccine (Include COVID-19) Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Vaccine (Include COVID-19) Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Vaccine (Include COVID-19) Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Vaccine (Include COVID-19)
Table 47. Key Market Challenges & Risks of Vaccine (Include COVID-19)
Table 48. Key Industry Trends of Vaccine (Include COVID-19)
Table 49. Global Vaccine (Include COVID-19) Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Vaccine (Include COVID-19) Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Vaccine (Include COVID-19) Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Vaccine (Include COVID-19) Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Sanofi Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 54. Sanofi Vaccine (Include COVID-19) Product Offered
Table 55. Sanofi Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Sanofi Main Business
Table 57. Sanofi Latest Developments
Table 58. CSL Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 59. CSL Vaccine (Include COVID-19) Product Offered
Table 60. CSL Main Business
Table 61. CSL Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. CSL Latest Developments
Table 63. GSK Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 64. GSK Vaccine (Include COVID-19) Product Offered
Table 65. GSK Main Business
Table 66. GSK Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. GSK Latest Developments
Table 68. Viatris Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 69. Viatris Vaccine (Include COVID-19) Product Offered
Table 70. Viatris Main Business
Table 71. Viatris Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Viatris Latest Developments
Table 73. AstraZeneca Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 74. AstraZeneca Vaccine (Include COVID-19) Product Offered
Table 75. AstraZeneca Main Business
Table 76. AstraZeneca Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. AstraZeneca Latest Developments
Table 78. Hualan Bio Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 79. Hualan Bio Vaccine (Include COVID-19) Product Offered
Table 80. Hualan Bio Main Business
Table 81. Hualan Bio Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Hualan Bio Latest Developments
Table 83. Changchun Institute of Biological Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 84. Changchun Institute of Biological Vaccine (Include COVID-19) Product Offered
Table 85. Changchun Institute of Biological Main Business
Table 86. Changchun Institute of Biological Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Changchun Institute of Biological Latest Developments
Table 88. Sinovac Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 89. Sinovac Vaccine (Include COVID-19) Product Offered
Table 90. Sinovac Main Business
Table 91. Sinovac Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Sinovac Latest Developments
Table 93. KM Biologics Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 94. KM Biologics Vaccine (Include COVID-19) Product Offered
Table 95. KM Biologics Main Business
Table 96. KM Biologics Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. KM Biologics Latest Developments
Table 98. Pfizer Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 99. Pfizer Vaccine (Include COVID-19) Product Offered
Table 100. Pfizer Main Business
Table 101. Pfizer Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Pfizer Latest Developments
Table 103. Merck Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 104. Merck Vaccine (Include COVID-19) Product Offered
Table 105. Merck Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Merck Main Business
Table 107. Merck Latest Developments
Table 108. Sinovac Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 109. Sinovac Vaccine (Include COVID-19) Product Offered
Table 110. Sinovac Main Business
Table 111. Sinovac Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. Sinovac Latest Developments
Table 113. Zhejiang Pukang Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 114. Zhejiang Pukang Vaccine (Include COVID-19) Product Offered
Table 115. Zhejiang Pukang Main Business
Table 116. Zhejiang Pukang Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Zhejiang Pukang Latest Developments
Table 118. Walvax Biotechnology Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 119. Walvax Biotechnology Vaccine (Include COVID-19) Product Offered
Table 120. Walvax Biotechnology Main Business
Table 121. Walvax Biotechnology Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. Walvax Biotechnology Latest Developments
Table 123. Bharat Biotech Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 124. Bharat Biotech Vaccine (Include COVID-19) Product Offered
Table 125. Bharat Biotech Main Business
Table 126. Bharat Biotech Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 127. Bharat Biotech Latest Developments
Table 128. Serum Institute Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 129. Serum Institute Vaccine (Include COVID-19) Product Offered
Table 130. Serum Institute Main Business
Table 131. Serum Institute Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 132. Serum Institute Latest Developments
Table 133. Panacea Biotec Ltd Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 134. Panacea Biotec Ltd Vaccine (Include COVID-19) Product Offered
Table 135. Panacea Biotec Ltd Main Business
Table 136. Panacea Biotec Ltd Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 137. Panacea Biotec Ltd Latest Developments
Table 138. Bio-Med Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 139. Bio-Med Vaccine (Include COVID-19) Product Offered
Table 140. Bio-Med Main Business
Table 141. Bio-Med Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 142. Bio-Med Latest Developments
Table 143. Halfkin Bio-Pharmaceuticals Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 144. Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Product Offered
Table 145. Halfkin Bio-Pharmaceuticals Main Business
Table 146. Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 147. Halfkin Bio-Pharmaceuticals Latest Developments
Table 148. LG Life Sciences Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 149. LG Life Sciences Vaccine (Include COVID-19) Product Offered
Table 150. LG Life Sciences Main Business
Table 151. LG Life Sciences Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 152. LG Life Sciences Latest Developments
Table 1. Vaccine (Include COVID-19) Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Inactivated Vaccine
Table 3. Major Players of Attenuated Vaccine
Table 4. Major Players of mRNA
Table 5. Major Players of Other
Table 6. Vaccine (Include COVID-19) Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Vaccine (Include COVID-19) Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Vaccine (Include COVID-19) Market Size Market Share by Type (2018-2023)
Table 9. Vaccine (Include COVID-19) Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Vaccine (Include COVID-19) Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Vaccine (Include COVID-19) Market Size Market Share by Application (2018-2023)
Table 12. Global Vaccine (Include COVID-19) Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Vaccine (Include COVID-19) Revenue Market Share by Player (2018-2023)
Table 14. Vaccine (Include COVID-19) Key Players Head office and Products Offered
Table 15. Vaccine (Include COVID-19) Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Vaccine (Include COVID-19) Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Vaccine (Include COVID-19) Market Size Market Share by Regions (2018-2023)
Table 20. Global Vaccine (Include COVID-19) Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Vaccine (Include COVID-19) Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Vaccine (Include COVID-19) Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Vaccine (Include COVID-19) Market Size Market Share by Country (2018-2023)
Table 24. Americas Vaccine (Include COVID-19) Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Vaccine (Include COVID-19) Market Size Market Share by Type (2018-2023)
Table 26. Americas Vaccine (Include COVID-19) Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Vaccine (Include COVID-19) Market Size Market Share by Application (2018-2023)
Table 28. APAC Vaccine (Include COVID-19) Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Vaccine (Include COVID-19) Market Size Market Share by Region (2018-2023)
Table 30. APAC Vaccine (Include COVID-19) Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Vaccine (Include COVID-19) Market Size Market Share by Type (2018-2023)
Table 32. APAC Vaccine (Include COVID-19) Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Vaccine (Include COVID-19) Market Size Market Share by Application (2018-2023)
Table 34. Europe Vaccine (Include COVID-19) Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Vaccine (Include COVID-19) Market Size Market Share by Country (2018-2023)
Table 36. Europe Vaccine (Include COVID-19) Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Vaccine (Include COVID-19) Market Size Market Share by Type (2018-2023)
Table 38. Europe Vaccine (Include COVID-19) Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Vaccine (Include COVID-19) Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Vaccine (Include COVID-19) Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Vaccine (Include COVID-19) Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Vaccine (Include COVID-19) Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Vaccine (Include COVID-19) Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Vaccine (Include COVID-19) Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Vaccine (Include COVID-19) Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Vaccine (Include COVID-19)
Table 47. Key Market Challenges & Risks of Vaccine (Include COVID-19)
Table 48. Key Industry Trends of Vaccine (Include COVID-19)
Table 49. Global Vaccine (Include COVID-19) Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Vaccine (Include COVID-19) Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Vaccine (Include COVID-19) Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Vaccine (Include COVID-19) Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Sanofi Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 54. Sanofi Vaccine (Include COVID-19) Product Offered
Table 55. Sanofi Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Sanofi Main Business
Table 57. Sanofi Latest Developments
Table 58. CSL Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 59. CSL Vaccine (Include COVID-19) Product Offered
Table 60. CSL Main Business
Table 61. CSL Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. CSL Latest Developments
Table 63. GSK Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 64. GSK Vaccine (Include COVID-19) Product Offered
Table 65. GSK Main Business
Table 66. GSK Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. GSK Latest Developments
Table 68. Viatris Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 69. Viatris Vaccine (Include COVID-19) Product Offered
Table 70. Viatris Main Business
Table 71. Viatris Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Viatris Latest Developments
Table 73. AstraZeneca Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 74. AstraZeneca Vaccine (Include COVID-19) Product Offered
Table 75. AstraZeneca Main Business
Table 76. AstraZeneca Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. AstraZeneca Latest Developments
Table 78. Hualan Bio Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 79. Hualan Bio Vaccine (Include COVID-19) Product Offered
Table 80. Hualan Bio Main Business
Table 81. Hualan Bio Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Hualan Bio Latest Developments
Table 83. Changchun Institute of Biological Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 84. Changchun Institute of Biological Vaccine (Include COVID-19) Product Offered
Table 85. Changchun Institute of Biological Main Business
Table 86. Changchun Institute of Biological Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Changchun Institute of Biological Latest Developments
Table 88. Sinovac Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 89. Sinovac Vaccine (Include COVID-19) Product Offered
Table 90. Sinovac Main Business
Table 91. Sinovac Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Sinovac Latest Developments
Table 93. KM Biologics Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 94. KM Biologics Vaccine (Include COVID-19) Product Offered
Table 95. KM Biologics Main Business
Table 96. KM Biologics Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. KM Biologics Latest Developments
Table 98. Pfizer Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 99. Pfizer Vaccine (Include COVID-19) Product Offered
Table 100. Pfizer Main Business
Table 101. Pfizer Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Pfizer Latest Developments
Table 103. Merck Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 104. Merck Vaccine (Include COVID-19) Product Offered
Table 105. Merck Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Merck Main Business
Table 107. Merck Latest Developments
Table 108. Sinovac Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 109. Sinovac Vaccine (Include COVID-19) Product Offered
Table 110. Sinovac Main Business
Table 111. Sinovac Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. Sinovac Latest Developments
Table 113. Zhejiang Pukang Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 114. Zhejiang Pukang Vaccine (Include COVID-19) Product Offered
Table 115. Zhejiang Pukang Main Business
Table 116. Zhejiang Pukang Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Zhejiang Pukang Latest Developments
Table 118. Walvax Biotechnology Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 119. Walvax Biotechnology Vaccine (Include COVID-19) Product Offered
Table 120. Walvax Biotechnology Main Business
Table 121. Walvax Biotechnology Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. Walvax Biotechnology Latest Developments
Table 123. Bharat Biotech Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 124. Bharat Biotech Vaccine (Include COVID-19) Product Offered
Table 125. Bharat Biotech Main Business
Table 126. Bharat Biotech Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 127. Bharat Biotech Latest Developments
Table 128. Serum Institute Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 129. Serum Institute Vaccine (Include COVID-19) Product Offered
Table 130. Serum Institute Main Business
Table 131. Serum Institute Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 132. Serum Institute Latest Developments
Table 133. Panacea Biotec Ltd Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 134. Panacea Biotec Ltd Vaccine (Include COVID-19) Product Offered
Table 135. Panacea Biotec Ltd Main Business
Table 136. Panacea Biotec Ltd Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 137. Panacea Biotec Ltd Latest Developments
Table 138. Bio-Med Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 139. Bio-Med Vaccine (Include COVID-19) Product Offered
Table 140. Bio-Med Main Business
Table 141. Bio-Med Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 142. Bio-Med Latest Developments
Table 143. Halfkin Bio-Pharmaceuticals Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 144. Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Product Offered
Table 145. Halfkin Bio-Pharmaceuticals Main Business
Table 146. Halfkin Bio-Pharmaceuticals Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 147. Halfkin Bio-Pharmaceuticals Latest Developments
Table 148. LG Life Sciences Details, Company Type, Vaccine (Include COVID-19) Area Served and Its Competitors
Table 149. LG Life Sciences Vaccine (Include COVID-19) Product Offered
Table 150. LG Life Sciences Main Business
Table 151. LG Life Sciences Vaccine (Include COVID-19) Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 152. LG Life Sciences Latest Developments
LIST OF FIGURES
Figure 1. Vaccine (Include COVID-19) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Vaccine (Include COVID-19) Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Vaccine (Include COVID-19) Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Vaccine (Include COVID-19) Sales Market Share by Country/Region (2022)
Figure 8. Vaccine (Include COVID-19) Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Vaccine (Include COVID-19) Market Size Market Share by Type in 2022
Figure 10. Vaccine (Include COVID-19) in Public
Figure 11. Global Vaccine (Include COVID-19) Market: Public (2018-2023) & ($ Millions)
Figure 12. Vaccine (Include COVID-19) in Private
Figure 13. Global Vaccine (Include COVID-19) Market: Private (2018-2023) & ($ Millions)
Figure 14. Global Vaccine (Include COVID-19) Market Size Market Share by Application in 2022
Figure 15. Global Vaccine (Include COVID-19) Revenue Market Share by Player in 2022
Figure 16. Global Vaccine (Include COVID-19) Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Vaccine (Include COVID-19) Market Size 2018-2023 ($ Millions)
Figure 18. APAC Vaccine (Include COVID-19) Market Size 2018-2023 ($ Millions)
Figure 19. Europe Vaccine (Include COVID-19) Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Vaccine (Include COVID-19) Market Size 2018-2023 ($ Millions)
Figure 21. Americas Vaccine (Include COVID-19) Value Market Share by Country in 2022
Figure 22. United States Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Vaccine (Include COVID-19) Market Size Market Share by Region in 2022
Figure 27. APAC Vaccine (Include COVID-19) Market Size Market Share by Type in 2022
Figure 28. APAC Vaccine (Include COVID-19) Market Size Market Share by Application in 2022
Figure 29. China Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Vaccine (Include COVID-19) Market Size Market Share by Country in 2022
Figure 36. Europe Vaccine (Include COVID-19) Market Size Market Share by Type (2018-2023)
Figure 37. Europe Vaccine (Include COVID-19) Market Size Market Share by Application (2018-2023)
Figure 38. Germany Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Vaccine (Include COVID-19) Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Vaccine (Include COVID-19) Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Vaccine (Include COVID-19) Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 52. APAC Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 53. Europe Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 55. United States Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 56. Canada Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 59. China Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 60. Japan Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 61. Korea Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 63. India Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 64. Australia Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 65. Germany Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 66. France Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 67. UK Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 68. Italy Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 69. Russia Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 70. Spain Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 73. Israel Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 76. Global Vaccine (Include COVID-19) Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Vaccine (Include COVID-19) Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Vaccine (Include COVID-19) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Vaccine (Include COVID-19) Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Vaccine (Include COVID-19) Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Vaccine (Include COVID-19) Sales Market Share by Country/Region (2022)
Figure 8. Vaccine (Include COVID-19) Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Vaccine (Include COVID-19) Market Size Market Share by Type in 2022
Figure 10. Vaccine (Include COVID-19) in Public
Figure 11. Global Vaccine (Include COVID-19) Market: Public (2018-2023) & ($ Millions)
Figure 12. Vaccine (Include COVID-19) in Private
Figure 13. Global Vaccine (Include COVID-19) Market: Private (2018-2023) & ($ Millions)
Figure 14. Global Vaccine (Include COVID-19) Market Size Market Share by Application in 2022
Figure 15. Global Vaccine (Include COVID-19) Revenue Market Share by Player in 2022
Figure 16. Global Vaccine (Include COVID-19) Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Vaccine (Include COVID-19) Market Size 2018-2023 ($ Millions)
Figure 18. APAC Vaccine (Include COVID-19) Market Size 2018-2023 ($ Millions)
Figure 19. Europe Vaccine (Include COVID-19) Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Vaccine (Include COVID-19) Market Size 2018-2023 ($ Millions)
Figure 21. Americas Vaccine (Include COVID-19) Value Market Share by Country in 2022
Figure 22. United States Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Vaccine (Include COVID-19) Market Size Market Share by Region in 2022
Figure 27. APAC Vaccine (Include COVID-19) Market Size Market Share by Type in 2022
Figure 28. APAC Vaccine (Include COVID-19) Market Size Market Share by Application in 2022
Figure 29. China Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Vaccine (Include COVID-19) Market Size Market Share by Country in 2022
Figure 36. Europe Vaccine (Include COVID-19) Market Size Market Share by Type (2018-2023)
Figure 37. Europe Vaccine (Include COVID-19) Market Size Market Share by Application (2018-2023)
Figure 38. Germany Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Vaccine (Include COVID-19) Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Vaccine (Include COVID-19) Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Vaccine (Include COVID-19) Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Vaccine (Include COVID-19) Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 52. APAC Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 53. Europe Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 55. United States Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 56. Canada Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 59. China Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 60. Japan Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 61. Korea Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 63. India Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 64. Australia Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 65. Germany Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 66. France Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 67. UK Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 68. Italy Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 69. Russia Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 70. Spain Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 73. Israel Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Vaccine (Include COVID-19) Market Size 2024-2029 ($ Millions)
Figure 76. Global Vaccine (Include COVID-19) Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Vaccine (Include COVID-19) Market Size Market Share Forecast by Application (2024-2029)
